Skip to main content

Quebec Research Center Receives $12.8M for Gene Expression Study of Steriod Use

SAN FRANCISCO, Dec. 20 - The Centre Hospitalier Universitaire de Quebec received a commitment for $10 million Canadian ($6.4 million) each from Genome Quebec and Genome Canada to fund a project to study the changes in gene expression that occur from steroid treatment.


The funding is part of $40 million Canadian ($25.3 million) earmarked for Quebec by Genome Canada, the Canadian genomics research organization. Genome Quebec is the provincial arm of Genome Canada.


"Dr. Labrie's [of CHUQ] research work will lead to a better basic understanding of steroids' impact on the human genome and open up new and significant progress opportunities in the fight against disease," Martin Godbout, CEO of Genome Canada, said in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.